Kristina Torfgård

Kristina Torfgård

Director Ejecutivo en IRLAB THERAPEUTICS AB .
63 años
Health Technology
Commercial Services
Consumer Services

Perfil

Kristina Torfgård is currently Chief Executive Officer at IRLAB Therapeutics AB since 2024.
Formerly, Chief Executive Officer at Alzinova AB from 2019 to 2024.
Principal at AstraZeneca AB. Vice President-Clinical & Regulatory Affairs at Albireo Ltd. VP-Clinical, Regulatory Affairs & Global Project at Albireo AB from 2014 to 2017.
Vice President-Clinical & Regulatory Affairs at Albireo Pharma, Inc. from 2017 to 2019.
Education includes a doctorate from the University of Linköping.

Cargos activos de Kristina Torfgård

EmpresasCargoInicio
IRLAB THERAPEUTICS AB Director Ejecutivo 01/08/2024

Antiguos cargos conocidos de Kristina Torfgård.

EmpresasCargoFin
ALZINOVA AB Director Ejecutivo 31/07/2024
ALBIREO PHARMA, INC. Director Técnico/Científico/I+D -
Consejero General 01/02/2017
Corporate Officer/Principal -
Consejero General -
Ver el detalle de la experiencia de Kristina Torfgård.

Formación de Kristina Torfgård.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

14

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Kristina Torfgård